Oral antiviral prophylaxis for prevention of recurrent herpes simplex infection after corneal grafting - a pilot study
Completed
- Conditions
- Infections and Infestations: HerpesInfections and InfestationsHerpes
- Registration Number
- ISRCTN58278320
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Not provided at time of registration
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie HSV recurrence after corneal grafting in ISRCTN58278320?
How does oral antiviral prophylaxis compare to standard-of-care in preventing HSV recurrence post-transplant?
Are there specific biomarkers that predict response to antiviral prophylaxis in HSV corneal infections?
What are the potential adverse events associated with long-term antiviral use in corneal transplant recipients?
What combination therapies are being explored for HSV prevention in corneal grafting studies?